Insulin Flashcards

1
Q

Original rapid/short-acting insulin

A

Regular insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Regular insulin preparation

A

Prepared with physiologic level of zinc and no added protein (readily soluble and rapidly absorbed)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Regular insulin vs. isophane insulin onset, peak, duration

A

30 minutes-1 hour, 2-4 hours, 5-8 hours

vs. 1-2 hours, 6-12 hours, 18-24 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

An insulin complex with the protein protamine at neutral pH, slower absorption and longer action than regular insulin

A

Isophane insulin (NPH)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

IV use of regular insulin vs. isophane insulin

A

True solution (clear- okay for IV) vs. cloudy suspension (NOT okay, can clog the line)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Injection time of regular insulin in regards to meals

A

PRIOR to meal (~30 minutes)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Isophane insulin use

A

Between-meal use (longer duration of action than regular insulin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Regular insulin use

A

Pre-meal use (more immediate than isophane, shorter duration, timing is critical though…)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

3 rapid insulins

A
Insulin lispro (Homolog)
insulin aspart (Novolog)
insulin glulisine (Apidra)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Insulin lispro:
Absorption and duration compared to regular insulin
Peak time and duration time
Injection time (timing significance)

A
  • Faster absorption and shorter duration (no aggregates formed
  • 30-60 min peak
  • 3-4 hour duration
  • injected immediately before meals (timing less critical)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Insulin lispro and insulin aspart: less risk of ____ from delayed meal and less risk of ____ after a meal

A

HYPOglycemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Similar onset as lispro, somewhat longer duration
Injected @ meal-time
Kinetics are between regular insulins & insulin lispro

A

Insulin aspart (Novolog)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Kinetics similar to regular, lispro, aspart

Injected BEFORE or IMMEDIATELY AFTER meal

A

Insulin glulisine (Apidra)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Can you use the 3 rapid insulin analogs for IV use?

A

Yes (previously only used regular insulin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Isophane (NP) formulation of rapid insulin analogs are formulated with ____ to slow their action for ____ effect

A

Protamine, between-meals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Only made in pre-formed mixtures with their non-isophane partners

A

Isophane (NP) formulations of rapid insulin analogs (70:30 NP-Aspart with Aspart)

17
Q

2 slow insulins

A

Insulin glargine (Lantus), Insulin detemir (Levemir)

18
Q

Formulated with zinc at ph=4 to slow dissolution (zinc and low pH stabilize the slowly soluble hexamer form)

A

Insulin glargine

19
Q

Clear solution that precipitates in SC tissue (ph 7.4)

Administered SC once daily, usually at bedtime

A

Insulin glargine

20
Q

Myristic acid attached, which makes it bind to albumin, which prolongs its action
Neutral pH

A

Insulin detemir (Levemir)

21
Q

Detemir difference from glargine

A

Better and less variable absorption, somewhat shorter action so may need 2 injections daily

22
Q

Why are long-acting insulins usually injected at bedtime?

A

Nighttime glucose production by liver

23
Q

Pros/Cons with intensive therapy for glucose control

A

Pros: beneficial (per Diabetes Control and Complications Trial)
Cons: closer monitoring, more frequent injections, risk for hypoglycemia

24
Q

Side effects of insulins (4)

A
  1. Insulin-induced hypoglycemia
  2. Immunologic reactions and injection site problems
  3. Weight gain
  4. Drug interactions (many)
25
Sympathoadrenal symptoms of hypoglycemia:
Sweating, weakness, hunger, tachycardia, anxiety, tremor
26
CNS symptoms of hypoglycemia:
Headache, blurred vision, mental confusion, incoherent speech, coma, convulsions
27
Treatment for severe hypoglycemia (esp. when patient is unconscious)
Glucagon administered IM or SC
28
Analog of amylin, a peptide hormone released from beta cells along with insulin
Pramlintide
29
MOA of pramlintide:
- Decreases post-prandial glucose (decreases short-acting insulin requirement) - decreases glucagon (limits fluctuations) - slows gastric emptying - increases satiety (avoids weight gain with insulin)
30
Use of pramlintide:
Used for Type 1 or 2 diabetics already on insulin, but not controlled (also LACK of weight gain is a plus)
31
Pramlintide administration
SC before meals along with insulin
32
AEs: mild nausea, headache, increased risk of hypoglycemia
Pramlintide (reduce dose of short-acting insulin)
33
Pramlintide avoidance in certain patients: (2)
1. Patients with decreased GI motility or absorption | 2. Renal disease (renally excreted)